CTI BIOPHARMA CORP Annual Return On Assets in % from 2012 to 2022

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Cti Biopharma Corp quarterly/annual Return On Assets history and growth rate from 2012 to 2022.
  • Cti Biopharma Corp Return On Assets for the quarter ending March 31, 2023 was -55.8 %, a 54.7% increase year-over-year.
  • Cti Biopharma Corp annual Return On Assets for 2022 was -72.2 %, a 45.8% increase from 2021.
  • Cti Biopharma Corp annual Return On Assets for 2021 was -133 %, a 81.4% decline from 2020.
  • Cti Biopharma Corp annual Return On Assets for 2020 was -73.4 %, a 13.2% decline from 2019.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2022 -72.2 +61.1 +45.8% Jan 1, 2022 Dec 31, 2022
2021 -133 -59.8 -81.4% Jan 1, 2021 Dec 31, 2021
2020 -73.4 -8.59 -13.2% Jan 1, 2020 Dec 31, 2020
2019 -64.8 -35.4 -120% Jan 1, 2019 Dec 31, 2019
2018 -29.5 +35.2 +54.4% Jan 1, 2018 Dec 31, 2018
2017 -64.7 -7.14 -12.4% Jan 1, 2017 Dec 31, 2017
2016 -57.6 +81.4 +58.6% Jan 1, 2016 Dec 31, 2016
2015 -139 -9.88 -7.66% Jan 1, 2015 Dec 31, 2015
2014 -129 -62.1 -92.8% Jan 1, 2014 Dec 31, 2014
2013 -66.9 +144 +68.2% Jan 1, 2013 Dec 31, 2013
2012 -211 Jan 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.